Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR10Q1 Inhibitors

OR10Q1 inhibitors are chemical compounds that target and inhibit the activity of the olfactory receptor OR10Q1, which belongs to the G-protein-coupled receptor (GPCR) superfamily. OR10Q1 is part of a large and diverse family of olfactory receptors that play a role in detecting and processing odorant molecules, a fundamental aspect of the olfactory system in humans and animals. GPCRs, including OR10Q1, transduce extracellular signals into intracellular responses through the interaction with G-proteins, which initiate a cascade of signaling events within the cell. By inhibiting OR10Q1, these chemical compounds prevent the receptor from binding to its specific ligands, thereby modulating the olfactory signaling pathway that would normally be triggered by those interactions.

Structurally, OR10Q1 inhibitors often contain functional groups designed to specifically interact with key residues in the ligand-binding domain of the receptor, preventing its activation. The inhibitors may be characterized by their selective binding affinities, which allow them to specifically target OR10Q1 without affecting other olfactory or GPCR receptors. This selectivity is crucial in ensuring precise modulation of OR10Q1-related signaling pathways, which are involved in more than just olfactory perception, as OR10Q1 can be expressed in various tissues. Research into OR10Q1 inhibitors often focuses on their molecular docking properties, structure-activity relationships, and the biochemical pathways they influence. The inhibition of OR10Q1 provides insights into receptor function, the broader olfactory signaling mechanism, and the chemical specificity underlying receptor-ligand interactions. These studies contribute to a deeper understanding of molecular recognition and signaling transduction within the GPCR family.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin might downregulate OR10Q1 expression by inhibiting the activation of NF-κB, a transcription factor that could be involved in the transcriptional initiation of the OR10Q1 gene.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol could decrease OR10Q1 expression by elevating the levels of sirtuins that deacetylate histones associated with the OR10Q1 promoter region, leading to a more condensed chromatin state and reduced transcription.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG may reduce OR10Q1 expression by altering DNA methylation patterns within the gene′s promoter region, thereby silencing its transcriptional activity.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic acid might decrease OR10Q1 expression by binding to retinoic acid receptors that interact with the promoter region of OR10Q1, suppressing its transcription.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin may downregulate OR10Q1 expression by increasing intracellular cAMP, which could activate protein kinase A (PKA) and lead to phosphorylation of transcription factors that repress OR10Q1 gene transcription.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Sodium butyrate might reduce OR10Q1 expression by inhibiting histone deacetylases, leading to hyperacetylation of histones and the suppression of transcriptionally active chromatin at the OR10Q1 locus.

3,3′-Diindolylmethane

1968-05-4sc-204624
sc-204624A
sc-204624B
sc-204624C
sc-204624D
sc-204624E
100 mg
500 mg
5 g
10 g
50 g
1 g
$36.00
$64.00
$87.00
$413.00
$668.00
$65.00
8
(1)

DIM could decrease OR10Q1 expression by altering estrogen receptor-mediated transcriptional repression mechanisms that target the OR10Q1 gene promoter.

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$62.00
$260.00
21
(1)

Ketoconazole might inhibit OR10Q1 expression by reducing the synthesis of steroid hormones that are potential upstream regulators of OR10Q1 gene transcription.

Bisphenol A

80-05-7sc-391751
sc-391751A
100 mg
10 g
$300.00
$490.00
5
(0)

BPA could decrease the expression of OR10Q1 by interfering with the hormonal signaling pathways that are essential for the maintenance of OR10Q1 gene transcription.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$76.00
$82.00
$367.00
36
(1)

Dexamethasone might suppress OR10Q1 expression by activating glucocorticoid receptors that bind to glucocorticoid response elements in the OR10Q1 promoter region, leading to transcriptional repression.